The chief executive of America’s oldest pro-life organization told Fox News Digital that President Donald Trump’s FDA nominee, Dr. Heidi Overton, could bring renewed scrutiny to mifepristone, the abortion drug at the center of an ongoing federal safety review.
John Mize, CEO of Americans United for Life (AUL), said he has had five or six conversations with Overton, who is known for her pro-life views. She currently serves as Trump’s deputy assistant for domestic policy.
“I think she’s going to bring objectivity to the issue of mifepristone in a way that will expose this drug for the damage it causes women,” Mize said in an interview on Friday…
Read the full article at FOXNEWS.COM
